• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质序列保守性与稳定的分子进化揭示流感病毒核蛋白是一个通用的可成药靶点。

Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target.

作者信息

Babar Mustafeez Mujtaba, Zaidi Najam-us-Sahar Sadaf

机构信息

Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, H-12, Kashmir Highway, Islamabad 44000, Pakistan.

Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, H-12, Kashmir Highway, Islamabad 44000, Pakistan.

出版信息

Infect Genet Evol. 2015 Aug;34:200-10. doi: 10.1016/j.meegid.2015.06.030. Epub 2015 Jun 30.

DOI:10.1016/j.meegid.2015.06.030
PMID:26140959
Abstract

The high mutation rate in influenza virus genome and appearance of drug resistance calls for a constant effort to identify alternate drug targets and develop new antiviral strategies. The internal proteins of the virus can be exploited as a potential target for therapeutic interventions. Among these, the nucleoprotein (NP) is the most abundant protein that provides structural and functional support to the viral replication machinery. The current study aims at analysis of protein sequence polymorphism patterns, degree of molecular evolution and sequence conservation as a function of potential druggability of nucleoprotein. We analyzed a universal set of amino acid sequences, (n=22,000) and, in order to identify and correlate the functionally conserved, druggable regions across different parameters, classified them on the basis of host organism, strain type and continental region of sample isolation. The results indicated that around 95% of the sequence length was conserved, with at least 7 regions conserved across the protein among various classes. Moreover, the highly variable regions, though very limited in number, were found to be positively selected indicating, thereby, the high degree of protein stability against various hosts and spatio-temporal references. Furthermore, on mapping the conserved regions on the protein, 7 drug binding pockets in the functionally important regions of the protein were revealed. The results, therefore, collectively indicate that nucleoprotein is a highly conserved and stable viral protein that can potentially be exploited for development of broadly effective antiviral strategies.

摘要

流感病毒基因组的高突变率以及耐药性的出现,需要不断努力去确定替代药物靶点并开发新的抗病毒策略。病毒的内部蛋白可被用作治疗干预的潜在靶点。其中,核蛋白(NP)是最丰富的蛋白,为病毒复制机制提供结构和功能支持。当前研究旨在分析核蛋白的蛋白质序列多态性模式、分子进化程度和序列保守性,作为其潜在成药可能性的函数。我们分析了一组通用的氨基酸序列(n = 22,000),为了识别并关联不同参数下功能保守的可成药区域,根据宿主生物体、毒株类型和样本分离的大陆区域对它们进行分类。结果表明,约95%的序列长度是保守的,各类别中该蛋白至少有7个区域保守。此外,高变区数量虽非常有限,但被发现受到正选择,这表明该蛋白针对各种宿主以及时空参照具有高度稳定性。此外,在该蛋白上绘制保守区域时,发现该蛋白功能重要区域有7个药物结合口袋。因此,这些结果共同表明核蛋白是一种高度保守且稳定的病毒蛋白,有可能被用于开发广泛有效的抗病毒策略。

相似文献

1
Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target.蛋白质序列保守性与稳定的分子进化揭示流感病毒核蛋白是一个通用的可成药靶点。
Infect Genet Evol. 2015 Aug;34:200-10. doi: 10.1016/j.meegid.2015.06.030. Epub 2015 Jun 30.
2
Global geno-proteomic analysis reveals cross-continental sequence conservation and druggable sites among influenza virus polymerases.全球基因-蛋白质组学分析揭示了流感病毒聚合酶之间的跨大陆序列保守性和可成药位点。
Antiviral Res. 2014 Dec;112:120-31. doi: 10.1016/j.antiviral.2014.10.013. Epub 2014 Oct 31.
3
Large-scale analysis of influenza A virus nucleoprotein sequence conservation reveals potential drug-target sites.大规模分析甲型流感病毒核蛋白序列保守性揭示潜在的药物靶点。
Virology. 2014 Apr;454-455:40-7. doi: 10.1016/j.virol.2014.01.023. Epub 2014 Feb 22.
4
Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target.流感病毒核蛋白:结构、RNA 结合、寡聚化和抗病毒药物靶点。
Future Microbiol. 2013 Dec;8(12):1537-45. doi: 10.2217/fmb.13.128.
5
Influenza nucleoprotein: promising target for antiviral chemotherapy.流感核蛋白:抗病毒化疗的有前景靶点。
Antivir Chem Chemother. 2012 Jul 26;23(3):77-91. doi: 10.3851/IMP2235.
6
Designing and screening of universal drug from neem (Azadirachta indica) and standard drug chemicals against influenza virus nucleoprotein.从印楝(印度楝)和标准药物化学物质中设计和筛选抗流感病毒核蛋白的通用药物。
BMC Complement Altern Med. 2016 Dec 16;16(1):519. doi: 10.1186/s12906-016-1469-2.
7
Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins.甲型流感病毒序列的大规模分析揭示了非结构蛋白的潜在药物靶点位点。
J Gen Virol. 2009 Sep;90(Pt 9):2124-33. doi: 10.1099/vir.0.011270-0. Epub 2009 May 6.
8
Biological and genetic evolution of the nucleoprotein gene of human influenza A viruses.甲型流感病毒核蛋白基因的生物学与遗传学进化
J Gen Virol. 1989 Aug;70 ( Pt 8):2111-9. doi: 10.1099/0022-1317-70-8-2111.
9
A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins.托戈托病毒和甲型流感病毒核蛋白上的经典双分型核定位信号。
Virology. 1998 Oct 10;250(1):9-18. doi: 10.1006/viro.1998.9329.
10
Nucleotide sequence analysis of the nucleoprotein gene of an avian and a human influenza virus strain identifies two classes of nucleoproteins.对一株禽流感病毒和一株人流感病毒株的核蛋白基因进行核苷酸序列分析,鉴定出两类核蛋白。
Virology. 1986 Dec;155(2):345-55. doi: 10.1016/0042-6822(86)90198-4.

引用本文的文献

1
Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix Tetra, a Seasonal Hemagglutinin-Based Vaccine.基于核蛋白的通用流感疫苗OVX836与基于季节性血凝素的疫苗Fluarix Tetra联合使用的安全性和免疫原性。
Vaccines (Basel). 2025 May 23;13(6):558. doi: 10.3390/vaccines13060558.
2
Regulation of respiratory CD8+ T-cell immunity by suppressive monocyte-like dendritic cells (MCs).抑制性单核细胞样树突状细胞(MCs)对呼吸道CD8 + T细胞免疫的调节
J Immunol. 2025 May 1;214(5):977-994. doi: 10.1093/jimmun/vkae059.
3
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states.
不同寡聚状态下流感病毒核蛋白的多克隆抗体和单克隆抗体分析
Virus Res. 2025 May;355:199563. doi: 10.1016/j.virusres.2025.199563. Epub 2025 Mar 24.
4
Evaluation of Safety, Immunogenicity and Cross-Reactive Immunity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, in Older Adults.基于核蛋白的通用流感疫苗OVX836在老年人中的安全性、免疫原性和交叉反应性免疫评估。
Vaccines (Basel). 2024 Dec 11;12(12):1391. doi: 10.3390/vaccines12121391.
5
Inserting CTL Epitopes of the Viral Nucleoprotein to Improve Immunogenicity and Protective Efficacy of Recombinant Protein against Influenza A Virus.插入病毒核蛋白的细胞毒性T淋巴细胞表位以提高重组蛋白对甲型流感病毒的免疫原性和保护效力。
Biology (Basel). 2024 Oct 7;13(10):801. doi: 10.3390/biology13100801.
6
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states.对处于不同寡聚状态的流感病毒核蛋白的多克隆抗体和单克隆抗体的分析。
bioRxiv. 2024 Sep 12:2024.09.12.612748. doi: 10.1101/2024.09.12.612748.
7
Opportunities and challenges for T cell-based influenza vaccines.基于T细胞的流感疫苗的机遇与挑战。
Nat Rev Immunol. 2024 Oct;24(10):736-752. doi: 10.1038/s41577-024-01030-8. Epub 2024 May 2.
8
Fusion Protein Consisting of Hemagglutinin Small Subunit and Truncated Nucleoprotein as a Universal Influenza Vaccine Candidate: Starting In-Silico Evaluation Toward Expression.由血凝素小亚基和截短核蛋白组成的融合蛋白作为通用流感疫苗候选物:启动针对表达的计算机模拟评估
J Pharm Bioallied Sci. 2023 Jan-Mar;15(1):57-62. doi: 10.4103/jpbs.JPBS_114_18. Epub 2023 Apr 14.
9
The role of cell-mediated immunity against influenza and its implications for vaccine evaluation.细胞介导免疫对流感的作用及其对疫苗评估的影响。
Front Immunol. 2022 Aug 16;13:959379. doi: 10.3389/fimmu.2022.959379. eCollection 2022.
10
Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.甲型流感病毒核蛋白与基因片段非翻译区的相互作用有助于病毒基因表达的选择性调节。
J Virol. 2022 May 25;96(10):e0020522. doi: 10.1128/jvi.00205-22. Epub 2022 Apr 25.